Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Cash & Equivalents (2021 - 2025)

Tivic Health Systems (TIVC) has 5 years of Cash & Equivalents data on record, last reported at $3.5 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 63.86% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, up 63.86%, while the annual FY2024 figure was $2.0 million, 38.33% down from the prior year.
  • Cash & Equivalents reached $3.5 million in Q3 2025 per TIVC's latest filing, up from $975000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $12.8 million in Q1 2021 and bottomed at $700000.0 in Q1 2025.
  • Average Cash & Equivalents over 5 years is $5.0 million, with a median of $3.5 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 63.86% in 2025, down 73.6% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $12.8 million in 2021, then tumbled by 72.51% to $3.5 million in 2022, then dropped by 7.79% to $3.2 million in 2023, then plummeted by 38.33% to $2.0 million in 2024, then surged by 75.0% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $3.5 million in Q3 2025, $975000.0 in Q2 2025, and $700000.0 in Q1 2025.